Salix Pharmaceuticals

Salix Pharmaceuticals is an American specialty pharmacy company that offers innovative gastroenterology treatments. The company was founded in 1989 and is currently a subsidiary of Bausch Health.

History

Salix Pharmaceuticals was established in 1989 in California. The company was initially focused on the sales and marketing of endoscopy equipment. In 1994, Salix relocated to Raleigh, North Carolina, where it shifted its focus to the development and commercialization of drugs used in gastroenterology.

In 2009, Salix acquired Oceana Therapeutics, expanding its product portfolio to include treatments for gastrointestinal diseases. In 2015, Salix was acquired by Valeant Pharmaceuticals, which later rebranded as Bausch Health in 2018.

Products

Salix's product portfolio includes a wide range of treatments for various gastrointestinal conditions. Some of their key products include:

• Xifaxan (rifaximin): An antibiotic used to treat traveler's diarrhea and hepatic encephalopathy.
• Apriso (mesalamine): A medication used to treat ulcerative colitis.
• MoviPrep: A medication used to cleanse the colon before a colonoscopy.

Research and Development

Salix is committed to the research and development of new treatments for gastrointestinal diseases. The company's R&D efforts are focused on the development of innovative therapies that address unmet medical needs in the field of gastroenterology.

See Also

• Pharmaceutical industry in the United States
• List of pharmaceutical companies

References

<references />

External Links

• Official website

   This article is a pharmacology-related stub. You can help WikiMD by expanding it!

This article is a stub related to pharmacology. You can help WikiMD by expanding it!

• Salix Pharmaceuticals logo
  Salix Pharmaceuticals logo